- 专利标题： FGFR4 KINASE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF
-
申请号： EP20771072.4申请日： 2020-03-06
-
公开(公告)号： EP3936509A1公开(公告)日： 2022-01-12
- 发明人: WANG, Jinghan , YAO, Jinsuo , DUAN, Xiaowei , YUAN, Baokun , LIU, Xijie , JIAO, Nan , MIN, Wangyang , SUN, Ying , LU, Chang , SUN, Yinghui , ZHANG, Jiuqing , JI, Yeling , HOU, Deng
- 申请人： Shouyao Holdings (Beijing) Co., Ltd.
- 申请人地址： CN Beijing 100176 22nd Floor, 2205 Building 1-A Ronghua Middle Road 10, Economic and Technological Development Zone
- 代理机构： Hoffmann Eitle
- 优先权： CN201910602669 20190705
- 国际公布： WO2020182062 20200917
- 主分类号： C07D519/00
- IPC分类号： C07D519/00 ; C07D471/14 ; A61K31/438 ; A61K31/4995 ; A61K31/4375 ; A61K31/496 ; A61K31/499 ; A61K31/5386 ; A61K31/5377 ; A61K31/541 ; A61P35/00
摘要：
The invention relates to an FGFR4 kinase inhibitor, and the preparation method and use thereof. The invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, solvate, polymorph or tautomer thereof, and use thereof in the manufacture of a medicament for the treatment of an FGFR4 mediated disease.
公开/授权文献
信息查询
